Supernus Pharmaceuticals Inc (SUPN)
34.76
+0.79
(+2.33%)
USD |
NASDAQ |
Nov 04, 16:00
36.88
+2.12
(+6.10%)
After-Hours: 20:00
Supernus Pharmaceuticals Debt to Equity Ratio: 0.00 for June 30, 2024
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2024 | 0.00 |
| March 31, 2024 | 0.00 |
| December 31, 2023 | 0.00 |
| September 30, 2023 | 0.00 |
| June 30, 2023 | 0.00 |
| March 31, 2023 | 0.5272 |
| December 31, 2022 | 0.4536 |
| September 30, 2022 | 0.4707 |
| June 30, 2022 | 0.4765 |
| March 31, 2022 | 0.4833 |
| December 31, 2021 | 0.4649 |
| September 30, 2021 | 0.4624 |
| June 30, 2021 | 0.4715 |
| March 31, 2021 | 0.4852 |
| December 31, 2020 | 0.4857 |
| September 30, 2020 | 0.5043 |
| June 30, 2020 | 0.5306 |
| March 31, 2020 | 0.5694 |
| December 31, 2019 | 0.5797 |
| September 30, 2019 | 0.6122 |
| June 30, 2019 | 0.6449 |
| March 31, 2019 | 0.6944 |
| December 31, 2018 | 0.7273 |
| September 30, 2018 | 0.7718 |
| June 30, 2018 | 0.8244 |
| Date | Value |
|---|---|
| March 31, 2018 | 0.9044 |
| December 31, 2017 | 0.00 |
| September 30, 2017 | 0.00 |
| June 30, 2017 | 0.0064 |
| March 31, 2017 | 0.0161 |
| December 31, 2016 | 0.0217 |
| September 30, 2016 | 0.0333 |
| June 30, 2016 | 0.0404 |
| March 31, 2016 | 0.0439 |
| December 31, 2015 | 0.0805 |
| September 30, 2015 | 0.0737 |
| June 30, 2015 | 0.0856 |
| March 31, 2015 | 0.1238 |
| December 31, 2014 | 0.6443 |
| September 30, 2014 | 0.4007 |
| June 30, 2014 | 0.8592 |
| March 31, 2014 | 0.9774 |
| December 31, 2013 | 1.028 |
| September 30, 2013 | 4.832 |
| June 30, 2013 | 1.647 |
| March 31, 2013 | 0.4873 |
| December 31, 2012 | 0.3977 |
| September 30, 2012 | 1.040 |
| June 30, 2012 | 0.7322 |
| March 31, 2012 | 106.19 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
Jun 2023
0.5797
Maximum
Dec 2019
0.3666
Average
0.4715
Median
Jun 2021
Debt to Equity Ratio Benchmarks
| ACADIA Pharmaceuticals Inc | 0.00 |
| Regeneron Pharmaceuticals Inc | 0.0677 |
| United Therapeutics Corp | 0.0656 |
| Ligand Pharmaceuticals Inc | 0.00 |
| Myomo Inc | 0.00 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 1.316B |
| Total Liabilities (Quarterly) | 358.38M |
| Shareholders Equity (Quarterly) | 957.45M |
| Current Ratio | 1.915 |
| Net Debt Paydown Yield | 6.53% |